Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

Advertisement 

 

Breast-malignant, males, children

Lymphoma

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 5 October 2011

Last major update: October 2009

Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.

 

Definition

=========================================================================

● Criteria for primary breast lymphoma: (a) sufficient tissue for diagnosis; (b) close interaction between lymphoma infiltrate and breast tissue; (c) no evidence of widespread lymphoma at time of diagnosis; (d) no prior diagnosis of nonbreast lymphoma (Cancer 1972;29:1705)

● Secondary breast lymphoma has similar incidence as primary breast lymphoma, and is most common metastatic disease to breast

 

Epidemiology

=========================================================================

● Rare, <1% of all breast malignancies are primary breast lymphoma

● Usually ages 30-35 years (diffuse large B cell) or 55-60 years (diffuse large B cell or MALT-type)

● Screening mammography may be increasing detection of low-grade lymphoma

● No association between implants and lymphoma (Plast Reconstr Surg 2009;123:790), but see anaplastic lymphoma below

 

Treatment and prognosis

=========================================================================

● Low stage is favorable prognostic factor

● Unfavorable factors are young age and high stage (Leuk Lymphoma 2009;50:918)

● CNS is common site of relapse (BMC Cancer 2008 Apr 1;8:86)

● Treatment is radiation therapy, chemotherapy, Rituximab; no advantage to mastectomy (Ann Surg 2007;245:784)

 

Xray images

=========================================================================

 

CLL/SLL - contributed by Dr. Julia Braza, Beth Israel Deaconness Medical Center, Boston, Massachusetts

 

Subtypes

=========================================================================

Burkitt’s lymphoma:

● In African patients, may present with massive bilateral breast involvement

● Patients may be pregnant or lactating

● Less common than other subtypes (Cancer 2007;110:25)

 

Diffuse large B cell lymphoma:

● Most common subtype of primary breast lymphoma (Am J Hematol 2009;84:133)

● Typically poorer prognosis if high proliferative (Ki-67) activity and nongerminal center B cell phenotype (CD10-, MUM1+, Mod Pathol 2005;18:398)

● Better prognosis if germinal center phenotype (Leuk Res 2008;32:1847)

Case reports: 55 year old woman whose tumor exhibited clear cell change (Case of Week #217)

 

Follicular lymphoma:

● Usually stage I (65%) but 20% are stage III/IV             

                         

MALT lymphoma:

● Usually stage I, 10% bilateral, survival >90% at 5 years, no MALT1 gene rearrangement (Mod Pathol 2006;19:1402)

 

Marginal zone lymphoma:

● Relatively indolent behavior compared to other sites (Ann Oncol 2009 Jul 1 [Epub ahead of print])

 

Case reports

=========================================================================

Anaplastic large cell lymphoma

● ALK- cases associated with silicon implants (Archives 2003;127:e115, Arch Pathol Lab Med 2009;133:1383); odds ration of 18.2, although absolute risk is low (JAMA 2008;300:2030)

● Sarcomatoid variant (Archives 2002;126:723)

 

Burkitt’s lymphoma:

● 12 year old girl in Africa with giant bilateral tumors (Arch Gynecol Obstet 2009;279:743)

 

Diffuse large B cell lymphoma

● Bilateral, diagnosed by FNA (Archives 2005;129:694)

 

Follicular lymphoma

● Diagnosed by biopsy (J Med Case Reports 2007;1:113)

 

Marginal zone/MALT

● Bilateral MALT lymphoma #1 (Archives 2000;124:1233), #2 (World J Surg Oncol 2008;6:52)

● Marginal zone/MALT lymphoma-CD5+ (Hum Pathol 2003;34:1065)

● Collision tumor of invasive ductal NOS and MALT lymphoma (Archives 2004;128:99)

 

NK lymphoma, nasal type

● Post-transplant (Mod Pathol 2004;17:125)

 

T cell lymphoma, peripheral type

● 37 year old woman with breast mass (Case of the Week #192)

 

Gross description

=========================================================================

● Soft, gray-white

● 25% bilateral

● No skin retraction, no nipple discharge

 

Gross images

=========================================================================

 

Diffuse large B cell lymphoma

 

Follicular lymphoma is bulging and fleshy

 

Bulging, fleshy tumor (subtype not known)

 

Microscopic description

=========================================================================

● Varies by subtype - see Lymphoma chapters for more detail

 

Micro images

=========================================================================

 

Anaplastic large cell lymphoma:

                                               

Large cells with abundant cytoplasm                Associated with silicon implant

 

                                   

ALK- cases                                                        Various images

 

                       

Sarcomatoid variant      TIA+ and ALK+               Various stains

 

Burkitt’s lymphoma:

                                               

Lymphocytic infiltrate with starry sky pattern    Ki-67 staining is diffuse and strong

 

CLL/SLL, contributed by Dr. Julia Braza, Beth Israel Deaconness Medical Center, Boston, Massachusetts:

                                   

CD5                              CD20

 

Diffuse large B cell:

                                               

Large cells with 1 or more nucleoli                   Diffuse proliferation of large centroblasts

and starry sky macrophages

 

           

H&E and CD20              Weak bcl10+

 

           

Various images             Mixed with MALT

 

Follicular lymphoma:

           

Follicular lymphoma     bcl2 is positive

 

MALT lymphoma:

                       

Small cells with monocytoid cytoplasm             Bilateral tumor

 

bcl10+

 

Mantle cell lymphoma:

Various images

 

NK/T cell lymphoma:

                                               

Lobular pattern of infiltration                           Tumor cells have abundant cytoplasm

and irregular nuclei

 

                                               

Pan-keratin immunostain highlights                  TIA+ and CD56+

lymphoepithelial lesions

 

Peripheral T cell lymphoma:

           

CD8+ tumor

 

           

CD4+ large cell tumor   Cells have clear cytoplasm and mitotic activity

 

Cytology images

=========================================================================

 

                                               

Burkitt’s lymphoma - large cells with deeply     Dyscohesive cells:

basophilic cytoplasm and multiple                    subtype not specified  

intracytoplasmic lipid vacuoles, high N/C

ratio, hyperchromatic round nuclei

 

Positive stains

=========================================================================

● CD45, B or T cell markers

Other markers vary by subtype

 

Negative stains

=========================================================================

● Keratin (may stain lymphoepithelial lesions)

 

Differential diagnosis

=========================================================================

● Lobular carcinoma - usually linear or targetoid patterns, keratin+, CD45-

● Lymphoid hyperplasia - may resemble low grade B cell lymphomas

● Lymphocytic mastitis - may be difficult to differentiate on core biopsy (Breast Cancer 2009;16:141)

 

Additional references

=========================================================================

Am J Surg Pathol 1993;17:574, Mod Pathol 2000;13:599 (T cell lymphomas), Am J Surg Pathol 1994;18:288, Archives 1999;123:1208

 

End of Breast – Malignant, Males, Children > Lymphoma

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.